DOCTOR OF PHILIOSOPHY (PhD) Pharmaceutical Administration The Ohio State University 2009 MASTERS IN PUBLIC HEALTH (MPH) Epidemiology The Ohio State University 2008 MASTER OF SCIENCE (MS) Pharmacy and Health Care Administration The University of Toledo 2006 DIPLOMA IN MARKETING MANAGEMENT Business Management Welingkar Institute of Management, Mumbai, India 2004 BACHELOR OF SCIENCE Pharmaceutical Sciences K. M. Kundnani College of Pharmacy, Worli, Mumbai, India 2003

E D U C A T I O N

I am an Assistant Professor in the Department of Health Services Policy and Management of the Arnold School of Public Health at the University of South Carolina and an Adjunct Professor in the Clinical Pharmacy and Outcomes Sciences Department at the South Carolina College of Pharmacy. I bring a diverse perspective to health services research, having credentials in pharmacoeconomics, outcomes research, marketing and epidemiology. My training equips me to understand patient decision-making at the individual and population levels. My work falls in the area of personalized healthcare delivery with applications in cancer prevention and control. Currently my research is centered on optimizing the cancer care continuum by developing scientifically sound risk-based screening strategies for different subgroups to enhance early detection of cancer as well as understanding care-seeking and treatment preferences that influence healthcare decision making using techniques such as Conjoint Analysis and Discrete Choice Experiments among vulnerable populations.

P R O F E S S I O N A L P R O F I L E

803.354.7204

zaina.qureshi@gmail.com

Lexington, SC

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

WOC Employee Wm. Jennings Bryan Dorn Veterans Administration Medical Center, Columbia, SC. / Dec. 2013 – present

VA- IRB Committee (SRS subcommittee) PI on study titled, “Understanding the Impact of Prostate Cancer Screening among US Veterans”

Assistant Professor, Arnold School of Public Health, University of South Carolina, Columbia, SC. (Aug. 2012 – present)

Teaching: HSPM 719 “Health Services Research Methods II”, HSPM 775 “Managerial Epidemiology and Statistics for Healthcare”, HSPM 500 “Introduction to Healthcare Management”, HSPM 700 “Approaches and Concepts for Health Administrators”.

Guest Lecture: Committees Department Level - Masters in Health Administration, PhD in Health Services Policy and

Management Committee School Level: Academic Programs Advised MHA, MPH and doctoral students Applied for internal and federally funded grant programs HESA faculty advisor

Post-Doc Research Assistant, College of Pharmacy, University of South Carolina, Columbia, SC. (Jun. 2010 – Aug. 2012)

Contributed to the analysis, data interpretation, data presentation and manuscript preparation for projects. Assisted in putting together local and national grants including SBIR, NIH R01, R13, R18, R21, SCTR, U01,

U19 among others. Conducted secondary data analysis and published manuscripts on Medicare and Pharmaceutical fraud. Collected data using RADAR/SONAR methodology (from FDA sources including MedWatch) and published

manuscripts on serious adverse events associated with cancer drug use. Post-Doc Research Associate in Outcomes Research and Health Economics (Sep. 2009 – May. 2010) Rutgers University, College of Pharmacy, New Brunswick, NJ

Lectured and managed 230 undergraduates in a course titled, “Pharmacy Marketing Management.” Conducted secondary data analysis using Medical Expenditure Panel Survey to investigate the trends in

healthcare expenditure among elderly patients with concomitant diabetes and obesity. Teaching Assistant, College of Pharmacy, the Ohio State University, Columbus, OH. (Aug. 2007 – Aug. 2009)

Assisted in teaching 5 different courses at the graduate and undergraduate level.

E X P E R I E N C E

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

Ohio Department of Job and Family Services, Ohio Health Plans, Bureau of Clinical Management (Jun. 2008 – Sep. 2008)

Contributed to the design and testing of protocol to improve worker efficiency in analyzing insurance claims and support appropriate use and quality improvement

Gained experiences in proposal writing, IRB submission, study design and analysis plan development, data analysis using SAS, and project management within a government organization

Conceptualized, developed and implemented a burden of illness study for the Medicaid Breast and Cervical Cancer Project to ensure the main drivers of cost were cancer-related cost.

College of Public Health, The Ohio State University & Universal Health Care Action Network of Ohio, Columbus, Ohio. (Feb. 2008 – Dec. 2008)

Assisted in implementing “Consumer Voice for Affordable Health Care” project funded by the Columbus Medical Association Foundation, Columbus, Ohio.

Managed data collection, established the protocol for data management, analyzed data and assisted in the preparation of the final report for the initiative.

Research Assistant, College of Public Health and Centers for Health Outcomes, Policy and Evaluation Studies, The Ohio State University, Columbus, OH. (Jun. 2006 - Jul. 2007)

Assisted in conducting literature review, writing and editing a research grant to Ohio Medicaid. Evaluate the medical cost attributable to obesity among Ohio Medicaid population as part of the grant

proposal.

Graduate Research Assistant, College of Pharmacy, the Ohio State University, Columbus, OH. (Jun. 2006 – Aug. 2007)

Created an Excel database to examine Food and Drug Administration guidelines on labeling of pharmaceuticals for pregnant women.

Model comparing drug utilization and medication adherence in a retiree population.

Graduate Teaching/Research Assistant, College of Pharmacy, the University of Toledo, Toledo, OH. (Aug. 2004 - May 2006)

Coordinated surveys, designed, implemented and managed projects surrounding issues like obesity, depression, emergency contraception and medication therapy management. Assisted in teaching 7 different courses at the graduate and undergraduate level.

E X P E R I E N C E c o n t i n u e d

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

Veterans Administration VA- IRB Committee: SRS subcommittee (2013 – present) Palmetto Health Office of Community Health CHNA Steering Committee (2015 – present) University of South Carolina Faculty Senate SPARC Grant Reviewer Fellowships and Scholarships Committee Arnold School of Public Health Academic Programs Committee (2013 – present) Department of Health Services Policy and Management PhD Committee (2013 – present) MHA Committee (2014 – present) HESA Advisor (2014 – present) American Society of Clinical Oncology (2011 – present) Member Rho-Chi Pharmaceutical Honor Society, Upsilon Chapter (2007 – present) Member Upsilon Chapter of Rho-Chi, The Ohio State University (2007 – 2008) Historian Selected to be a liaison between the PharmD and graduate program students by the Department of Pharmacy Practice and Administration Chair. Provided meeting minutes and communicated information discussed at each meeting with graduate students in the program as well as authored the annual report for the chapter. International Society for Pharmacoeconomics and Outcomes Research (International Network) (2008 – 2009) Financial Committee Member International Society for Pharmacoeconomics and Outcomes Research (The Ohio State University Student Chapter) (2006-2009) -Vice-President 2008 – 2009 -Chapter President 2007 – 2008

Elected to be liaison between ISPOR and its student members, leading a council of 14 ISPOR student chapter members.

Organized and oversaw all student activities as well as recruited new members. Arranged educational teleconferences and authored ISPOR student newsletter.

-Treasurer 2006 – 2007

P R O F E S S I O N A L L E A D E R S H I P A N D S E R V I C E

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

P U B L I C A T I O N S

Published or in Press/ Submitted

2017 1. Qureshi ZP, Sartor OA, Bennett CL. Calling Order to Chaos: Treatment Decision-Making in Metastatic

Castrate Resistant Prostate Cancer (mCRPC). Urology. Sep 2017. doi: 10.1016/j.urology.2017.04.063.

2. Haider MR, Qureshi ZP, Khan MM. Effects of women's autonomy on maternal healthcare utilization in Bangladesh: Evidence from a national survey. Sex Reprod Healthc. 2017 Dec;14:40-47. doi: 10.1016/j.srhc.2017.09.002. Epub 2017 Sep 18.

3. Sabol R, Noxon V, Sartor O, Berger J, Qureshi ZP, et al. Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR). Cancer Medicine. 2017 Jun;6(7):1541-1551.

4. Noxon V, Knopf KB, Norris LB, Chen B, Yang YT, Qureshi ZP, et al. Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract. 2017 Jun;13(6):e562-e573. doi: 10.1200/JOP.2016.019364. Epub 2017 May 15.

American Public Health Association (APHA) Public Health Education and Health Promotion (PHEHP) (2017) Early Career Award Nomination James E Clyburn Health Disparities Lecture Series (2015) Best Poster Award Nomination International Society for Pharmacoeconomics and Outcomes Research (2015, 2009) Best Poster Award Nomination International Society for Pharmacoeconomics and Outcomes Research (2008) Student Activities Budget Grant International Society for Pharmacoeconomics and Outcomes Research (2008) Outstanding Service Award Midwest Social and Administrative Pharmacy Conference (2008) Consortium for Research in Administrative Pharmacy Podium Presentations Award Nomination deArce Memorial Endowment Fund In Support Of Medical Research & Development (2006) Research Grant Title “Assessing Knowledge and Skills of Pharmacists to Perform Disease Management Services”

H O N O R S A N D A W A R D S

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

5. Bhavsar GP, Probst JC, Bennett KJ, Hardin JW, Qureshi Z. Community-level electronic prescribing and

adverse drug event hospitalizations among older adults. Health Informatics J. 2017 Jul 1:1460458217720396. doi: 10.1177/1460458217720396. [Epub ahead of print]

6. Haider MR, Qureshi ZP, Horner R, Friedman DB, Bennett C. What have Patients been hearing from Providers since the 2012 USPSTF Recommendation against Routine Prostate Cancer Screening? Clin Genitourin Cancer. 2017 May 10. pii: S1558-7673(17)30126-X. doi: 10.1016/j.clgc.2017.05.002. [Epub ahead of print]

7. Barth KS, Ball S, Adams RS, Nikitin R, Wooten NR, Qureshi ZP, Larson MJ. Development and feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians. J Contin Educ Health Prof. 2017; 37(2): 98-105.

8. Qureshi ZP, Haider MR, Rodriguez-Monguio R, Wooten NR, Nikitin RV, Ball S, Barth K, Elk R, Horner R, Bennett CL. Opioid Prescription Drug Use and Expenditures in US Outpatient Physician Offices: Evidence from Two Nationally Representative Surveys. Canc Therapy & Oncol Int J 3(3): February 2017 DOI: 10.19080/CTOIJ.2017.03.555611

9. Qureshi ZP, Ganz PA, Bennett CL. Improving the Evidence Base for Delivery of High-Quality Cancer Care. JAMA Oncology. Published online Feb 16, 2017. doi:10.1001/jamaoncol.2016.6722.

2016

10. Yang YT, Nagai S, Chen B, Qureshi ZP, Lebby AA, Kessler S, Georgantopoulos P, Raisch D, Sartor O, Hermanson T, Kane RC, Hrushesky W, Riente JJ, Norris LB, Bobolts LR, Armitage JO, Bennett CL. Generic oncology drugs in developed and developing countries: are they all safe? The Lancet Oncology. 2016; 17(11):e493-e501.

11. Kaur K, Fayad R, Saxena A, Frizzell N, Chanda A, Das S, Chatterjee S, Hegde S, Baliga MS, Ponemone V, Rorro M, Greene J, Elraheb Y, Redd AJ, Bian J, Restaino J, Norris LB, Qureshi ZP et al. Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network. J Community Support Oncol. 2016 Feb;14(2):54-65. doi: 10.12788/jcso.0167.

12. Lin Y, McLain AC, Probst JC, Bennett KJ, Qureshi ZP, Eberth J. Health-Related Quality of Life among Adults 65 and Older in the United States, 2011-2012: A Multilevel Small Area Estimation Approach. Annals of Epidemiology. 2016, 27(1): 52-58.

13. Qureshi Z, Hrushesky W, Bennett C. Editorial Comment. Urology. 2016; 93:74-75. doi: 10.1016/j.urology.2016.02.059. Epub 2016 May 11.

2015

14. Wang L, McMahan CS, Hudgens MG, Qureshi ZP. A Flexible, Computationally Efficient Method for Fitting the Proportional Hazards Model to Interval-Censored Data. Biometrics. Biometrics. 2016 Mar;72(1):222-31. doi: 10.1111/biom.12389. Epub 2015 Sep 22.

P U B L I C A T I O N S c o n t i n u e d

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

P U B L I C A T I O N S c o n t i n u e d

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

15. Qureshi ZP, Bennett CL, Hermanson T, Horner R, Haider R, Lee M, Ablin R. Ethical Dilemmas Surrounding Prostate Specific Antigen (PSA) Screening for Prostate Cancer. Journal of Clinical Research & Bioethics. 2015; 6 (1):206. doi: 10.4172/2155-9627.1000206

16. Lu, Kevin, Chen, B., Li, S., Sartor, O., Qureshi, Z., Bennett, C. (2015). Health Care Fraud. The Sage Encyclopedia of Pharmacology and Society.

2014

17. Bennett CL, Chen B, Hermanson T, Wyatt M, Schulz R, Georgantopoulos P, Kessler S, Raisch D, Qureshi Z, et al. Regulatory and Clinical Considerations for Biosimilar Oncology Drugs. The Lancet Oncology. 2014; 15(13):e594-605.

18. Lu ZK, Kessler, SJ, Schulz R, Bian J, Chen B, Wu J, Noxon V, Rao G, Leibnitz R, Restaino J, Maxwell W, Norris B, Qureshi Z, et al. Systemic approach to pharmacovigilance beyond the limits: The Southern Network on Adverse Reactions (SONAR) projects. Adv Pharmacoepidem Drug Safety 2014; 3:149. doi: 10.4172/2167-1052.1000149

2013

19. Qureshi ZP, Magwood JS, Singh Sarveshwari, Bennett CL. Rituximab and biosimilars – equivalence and reciprocity. Dove Press. June 2013; (3): 19 – 25.

20. Bookstaver B, Bland CM, Qureshi ZP, Faulkner-Fennell CM, Sheldon MA, Caulder CR, Hartis C. Safety and Effectiveness of Daptomycin Across a Hospitalized Obese Population: Results of a Multicenter Investigation in the Southeastern United States. Pharmacotherapy. 2013. 33 (12): 1322-1330.

21. Magwood J, Murday AS, Zhu NY, Georgantopoulos P, Qureshi ZP, et al. Levamisole contamination of cocaine resulting in neutropenia and thrombovasculopathy: A report from the Southern Network on Adverse Reactions (SONAR). Community Oncology. 2013; 10: 364-367.

22. Bennett CL, Jacob S, Dunn BL, Georgantopoulos P, Zheng XL, Kwaan HC, McKoy JM, Magwood JS, Qureshi ZP, et al. Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). British Journal of Haematology, 2013, 161(6): 896–898.

2012

23. Jacob S, Dunn BL, Qureshi ZP, et al. Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty–Year Review. A report from the Southern Network on Adverse Reactions (SONAR). Seminars in Thrombosis & Hemostasis. Nov 2012; 38: 845-853.

24. Bennett CL, Spiegel DM, Macdougall IC, Norris L, Qureshi ZP, et al. A review of safety, efficacy, and utilization of eythropoiesis stimulating agents (ESAs) for patients with cancer or chronic kidney disease: A report from the Southern Network on Adverse Reactions (SONAR). Seminars in Thrombosis & Hemostasis. Nov 2012; 38: 783-796.

P U B L I C A T I O N S c o n t i n u e d

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

25. Chen B, Restaino J, Norris LB, Xirasagar S, Qureshi ZP, et al. A tale of two citizens: a state attorney general and a hematologist facilitate translation of research into FDA actions. Journal of Oncology Practice, Nov 2012; 8(6): e158-e167.

26. Bennett CL, Starko KM, Thomsen HS, Cowper S, Sartor AO, MacDougall I, Qureshi ZP, et al. Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye’s syndrome. A report from the SOuthern Network on Adverse Reactions (SONAR). Journal of General Internal Medicine, Dec 2012; 27(12): 1697-1703.

27. Bennett CL, Qureshi ZP, Sartor AO, Norris LB, Murday A, Xirasagar S, Thomsen HS. Gadolinium Induced Nephrogrenic Systemic Fibrosis, the Rise and Fall of an Iatrogenic Disease. Clinical Kidney Journal, 2012; 5: 82-88.

28. Matsumoto M, Bennett CL, Isonishi A, Qureshi ZP, Hori Y, Hayakawa M, Yoshida Y, Yagi H, Fujimura Y. Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan. PLoS ONE, 2012; 7(3): e33029.

2011

29. Bennett, CL, Qureshi ZP. Patient Safety: Identifying Adverse Drug Reactions. The Rx Consultant, 2011; 20(11): 1-8.

30. Qureshi ZP, Sartor O, Xirasagar S, Liu Y, Bennett CL. Pharmaceutical Fraud and Abuse in the United States: 1996-2010. Archives of Internal Medicine. 2011; 171(16):1503-1506.

31. Qureshi ZP, Norris LB, Sartor OA, McKoy JM, Armstrong J, Raisch DW, Garg V, Stafkey-Mailey D, Bennett CL. Caveat Oncologis: Clinical findings and consequences of distributing counterfeit erythropoietin in the United States. Journal of Oncology Practice, 2011; 8(2): 84-90.

32. Trenery A, Qureshi ZP, Rowen R, Day T, Norris LB, Bennett CL. First Bite Syndrome: An interesting complication of carotid body paraglioma resection. Community Oncology, 2011; 8(8): 375-378.

33. Raisch DW, Campbell W, Garg V, Qureshi ZP, Bookstaver B, Norris LB, Bennett CL. Description of Anaphylactic Reactions to Paclitaxel and Docetaxel Reported to the FDA, with a Focus on the Role of Premedication. Expert Opinion On Drug Safety Epub. 2011; 521-528.

34. Qureshi ZP, Liu Y, Sartor OA, Chu YH, Bennett CL. Enforcement Actions involving Medicaid Fraud and Abuse: 1996- 2009. Archives of Internal Medicine. 2011; 171(8):785-787.

35. Qureshi ZP, Seoane-Vazquez E, Rodriguez-Monguio R, Stevenson KB, Szeinbach SL. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009. Pharmacoepidemiology and Drug Safety, 2011; 20(7):772-777.

P U B L I C A T I O N S c o n t i n u e d

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

36. Qureshi ZP, Sartor O, Bennett CL. Radiation overdosing following brain perfusion CT scans in California, Florida and Alabama (2008-2009). Community Oncology. 2011; 8(2):89-91.

37. Rudisill C, Qureshi ZP, Armstrong JM, Norris LB, Bennett CL. A probable serotonin syndrome complicating a routine screening colonoscopy procedure. Community Oncology. 2011; 8(1):41-42.

2010

38. Norris LB, Qureshi Z, Barnato S, Lai S, Bennett C. Serious Adverse Drug Reactions (sADRS) Associated with Hematopoietic Growth Factors: A Systematic Review From the Southern Network on Adverse Reactions (SONAR) Program. Blood (ASH Annual Meeting Abstracts), Nov 2010; 116: 2555.

39. Bennett C, Qureshi Z. Finishing the Picture: Clopidogrel Is Indeed the Most Common Drug Associated with Thrombotic Thrombocytopenic Purpura (TTP) In FDA Databases: Its Mechanism, Laboratory Findings, Clinical Features, and Epidemiology Differ From That Associated with Ticlopidine. Blood (ASH Annual Meeting Abstracts), Nov 2010; 116: 1527.

40. Norris LB, Qureshi ZP, Bookstaver B, Raisch DW, Sartor O, Chen H, Chen F, Bennett CL. Polysorbate 80 hypersensitivity reactions: a renewed call to action. Community Oncology. 2010; 7(9):425-428.

2009

41. Qureshi Z, Szeinbach S, Seoane-Vazquez E, Stevenson K. Market Discontinuation of Pharmaceuticals in the United States (Dissertation). Columbus: Pharmaceutical Administration, The Ohio State University; 2009.

2008

42. Qureshi Z, Hecht D. Medicaid Breast and Cervical Cancer Program. In: Bureau of Clinical Management, Ohio Department of Job and Family Affairs (Internal Documents); 2008.

2006

43. Qureshi Z, Holiday-Goodman H, Siganga W, Powers M, Pinto S. Pharmacists’ Counseling Practices for Obese Patients (Thesis). Toledo: Pharmacy and Health Care Administration, University of Toledo; 2006.

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

1. Sriram S, Qureshi ZP, et al. Availability of Medical Personnel in Primary Health Care Setting and Maternal Mortality in India. 2017. American Public Health Association, Annual Meeting, Atlanta, GA.

2. Mehrabi A, Noochpoung R, Calef, C, Sriram S, Qureshi ZP. Gender Differences in Fluoroquinolone Induced Suicide Rates. 2017. American Public Health Association, Annual Meeting, Atlanta, GA.

3. Sriram S, Khan M, Qureshi SP, Siddiqi K. Effect of Barriers in Service Utilization on Emergency Department Utilization by Children of age 1-17 years. 2017. American Public Health Association, Annual Meeting, Atlanta, GA.

4. Calef, C, Chinaeke E, Sriram S, Mehrabi A, Noochpoung R, Qureshi ZP, Horner R. Developing attributes for colorectal cancer screening: A systematic review of patient preferences literature. 2017. American Public Health Association, Annual Meeting, Atlanta, GA.

5. Sriram S, Mehrabi A, Noochpoung R, Calef, C, Chinaeke E, Qureshi ZP, Bennett C. 100% Response Rate to Research Investigator Request to Voluntarily Participate in a Survey of Persons with Ciprofloxacin -Associated Neuropsychiatric Toxicity and to provide a DNA sample. 2017. American Public Health Association, Annual Meeting, Atlanta, GA.

A B S T R A C T S

P U B L I C A T I O N S c o n t i n u e d

Papers in Progress

1. Battling Fear: A Potential Key to Improving Colorectal Cancer Screening

2. Colorectal Cancer Costs in the US: Evidence from the Medical Expenditure Panel Survey

3. Developing attributes for Prostate Cancer Treatment

4. Shared decision making in patients suffering from advanced prostate cancer

Non-Peer Reviewed Publications

1. Qureshi Z.P., Wilke C. ISPOR Student Network Aims to Support Students Worldwide. ISPOR

Connections 14(4):17.

2. Making Ends Meet: What Can Franklin County Residents Afford to Pay for Health Care? A Report in

collaboration with Universal Health Care Action Network of Ohio.

A B S T R A C T S c o n t i n u e d

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

6. Mehrabi A, Qureshi ZP, Demir I. Estimation of Ischemic Heart Disease (IHD) Effects on Congestive Heart Failure (CHF) Development: A Logistic Regression Approach. 2017. American Public Health Association, Annual Meeting, Atlanta, GA.

7. Calef C, Chinaeke E, Sriram S, Mehrabi A, Noochpoung R, Qureshi ZP, Bennett CL. Suicidal Events (SE) After Short and Long Term Exposure to Fluoroquinolones. 2017. American Public Health Association, Annual Meeting, Atlanta, GA.

8. Merrell M, Haider M, Qureshi ZP. Association of Financial Incentives with Patient-Centered Medical Home Adoption among Primary Care Physicians. Value in Health. May 2017. Vol. 20, Issue 5, Page A377.

9. Haider M, Qureshi ZP, Khan M. Association of Patient-Centered Care and Seeking Insurance from Health Exchanges by the Low-Income People: Evidence from the Health Information National Trend Survey. Value in Health. May 2016. Vol. 19, Issue 3, Page A33.

10. Qureshi ZP, Jindal M, Farr D, Brandt H, Workman L, Horner R. Understanding Preferences for Colorectal Cancer Screening. Value in Health. May 2016. Vol. 19, Issue 3, Page A307.

11. Qureshi ZP, Haider R, Probst J, Horner R, Bennett CL. Opioid prescription trends in the rural US: Evidence from the National Ambulatory Medical Care Survey (NAMCS) data 2006-2010. May 2015. Vol. 18, Issue 3, Page A214.

12. Qureshi ZP, Ball S, Horner R, et al. Determining patterns of Opioid Misuse and Misprescribing in South Carolina. Value in Health. May 2015. Vol. 18, Issue 3, Page A302-303.

13. Haider R, Qureshi ZP, et al. Factors predicting receipt of Prostate Specific Antigen (PSA) testing: Evidence from the National Ambulatory Medical Care Survey (NAMCS) Data. May 2015. Vol. 18, Issue 3, Page A274.

14. Haider R, Qureshi ZP, et al. Colorectal Cancer (CRC) costs in the US: findings from the Medical Expenditure Panel Survey 2008-2012. May 2015. Vol. 18, Issue 3, Page A270-271.

15. Qureshi ZP, Lee M, Horner R, Bennett CL. Battling fear: a potential key to improving Colorectal Cancer Screening. Value in Health. May 2015. Vol. 18, Issue 3, Page A50.

16. Haider M, Qureshi ZP, et al. Cancer Care Costs Trend in the United States: Findings From the Medical Expenditure Panel Survey 2008-2011. Value in Health. May 2014. Vol. 17, Issue 3, Page A100.

17. Haider M, Qureshi ZP, et al. Prostate Cancer Care Cost Trends in the US: Findings from the Medical Expenditure Panel Survey 2008-2011. International Health Economics Association Dublin, Ireland. 2014.

A B S T R A C T S c o n t i n u e d

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

18. Haider M, Qureshi ZP, et al. Estimating Prostate Cancer Care Cost in the US: Findings from the Medical Expenditure Panel Survey 2008-2011 APHA Annual Meeting, New Orleans, November 2014.

19. Lu K, Chen B, Qureshi ZP, et al. Health care fraud 2006 to 2011. Value in Health. Volume 16, Issue 3, Page A198, 2013.

20. Crawford D, Qureshi ZP, et al. Estimating the cost for Prostate Cancer Screening Using the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Data. Value in Health. Volume 16, Issue 3, Page A151, 2013.

21. Li, Y.J., Xirasagar, S., Qureshi, Z., Hurley, T.G., Hardin, J.W., Zhang, J., & Wirth, M. (2013, November). Assessment of an innovative colonoscopy protocol using a 2-person technique and propofol sedation in ensuring high quality screening colonoscopies by trained primary care physicians. Podium session presented at the American Public Health Association, 141st Annual Meeting, Boston, MA.

22. Tsai, M.H., Xirasagar, S., Li, Y.J., & Qureshi, Z. (2013, November). Colonoscopy screening among Americans with a family history of colorectal cancer. Podium session presented at the American Public Health Association 141st Annual Meeting, Boston, MA.

23. Li, Y.J., Xirasagar, S., Hurley, T.G., Hardin, J., Wirth, M., & Qureshi, Z.P. (2013, June). Comparison of innovations in screening colonoscopy protocols (2-person technique and propofol sedation) in improving adenoma detection rates. Poster session presented at Academy Health’s 2013 Annual Research Meeting (ARM), Baltimore, MD.

24. Lu, Z., Qureshi, Z. P., et al. (2012, November). Why Is Cancer Care So Expensive: Potential Implications of Fraud and Abuse. In BLOOD (Vol. 120, No. 21). L ST NW, Suite 900, Washington, DC 20036 USA: Amer Soc Hematology.

25. Bennett, C., Matsumoto, M., Georgantopoulos, P., Jacob, S., Dunn, B. L., Qureshi, Z. P., et al. (2012, November). Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000. In Blood (Vol. 120, No. 21). 2021 L ST NW, Suite 900, Washington, DC 20036 USA: Amer Soc Hematology.

26. Tennant, S. J., Caulder, C. R., Bookstaver, P. B., & Qureshi, Z. (2012, October). Assessing medication adherence in an HIV/AIDS patient population: one pill versus three pills as a once a day regimen. In Pharmacotherapy (Vol. 32, No. 10, pp. E291-E291). 111 River St, Hoboken 07030-5774, NJ USA: Wiley-Blackwell.

27. Qureshi, Z., and C. Bennett. "PUK33 Cost-Utility Analysis of Alternative Treatments for Moderate Grade Vesicoureteral Reflux." Value in Health 15.4 (2012): A158-A158.

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

A B S T R A C T S c o n t i n u e d

28. Lu, Z., Qureshi, Z., Felder, T., Lopez, I., Xirasagar, S., Sartor, O., & Bennett, C. (2012). PHP14 Federal Actions Involving Health Care Fraud and Abuse (2006-2010). Value in Health, 15(4), A15.

29. Lu, Z. K., Qureshi, Z. P., Cho, M., Wang, T. P., Yan, H., Bennett, C. L., & Chang, V. T. S. (2012, May). Impact of racial and marital status on health services utilization among veterans with terminal cancer. In Journal of Clinical Oncology (Vol. 30, No. 15). 2318 Mill Road, Ste 800, Alexandria, VA 22314 USA: Amer Soc Clinical Oncology.

30. Investigating the effect of an educational pharmacy camp on high school students’ interest, understanding, and perception of the profession – ASHP Midyear Clinical Meeting 2012.

31. Qureshi Z.P., Armstrong J., Bennett C.L. “Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty Year Review.” Blood (ASH Annual Meeting Abstracts), Nov 2011; 118: 2226.

32. Norris L., Mattison D., Qureshi Z.P., Bennett C.L. “Location, Location, Location: Reassessing Erythropoiesis Stimulating Agents (ESAs) in the United States (US), Canada, and Europe (2007–2011).” Blood (ASH Annual Meeting Abstracts), Nov 2011; 118: 4753.

33. Qureshi Z.P., Sartor O.A., Bennett C.L."Federal Enforcement Actions Against Fraud And Abuse By Pharmaceutical Manufacturers: 1996- 2010." The International Society for Pharmacoeconomics and Outcomes Research, Baltimore, Maryland, May 2011. (Poster Presentation)

34. Norris LB, Qureshi Z, Barnato S, Lai S, Bennett C. Serious Adverse Drug Reactions (sADRS) Associated with Hematopoietic Growth Factors: A Systematic Review From the Southern Network on Adverse Reactions (SONAR) Program. Blood (ASH Annual Meeting Abstracts), Nov 2010; 116: 2555.

35. Qureshi Z.P., Pinto S. “Assessing Knowledge and Skills of Pharmacists to Perform Disease Management Services.” American Pharmacists Association Annual Convention, San Francisco, CA, March 2006. (Poster Presentation)

36. Bennett C, Qureshi Z. Finishing the Picture: Clopidogrel Is Indeed the Most Common Drug Associated with Thrombotic Thrombocytopenic Purpura (TTP) In FDA Databases: Its Mechanism, Laboratory Findings, Clinical Features, and Epidemiology Differ From That Associated with Ticlopidine. Blood (ASH Annual Meeting Abstracts), Nov 2010; 116: 1527.

37. Qureshi Z.P., Seoane-Vazquez E., Szeinbach S., Stevenson K. “A Trend Analysis of Discontinued New Molecular Entities in the US.” The International Society for Pharmacoeconomics and Outcomes Research, Atlanta, Georgia, May 2010. (Poster Presentation)

38. Qureshi Z.P., Szeinbach S.L., Seoane-Vazquez E., Rodriguez R., “Market Discontinuation of Pharmaceuticals in the United States: Analysis of Drugs Approved by the FDA from 1939 to 2008.” The International Society for Pharmacoeconomics and Outcomes Research, Orlando, Florida, May 2009. (Poster Presentation)

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

A B S T R A C T S c o n t i n u e d

39. Szeinbach S.L., Beyer A.P., Qureshi Z.P., Uhas A.A., Visaria J., Seoane-Vazquez E. “Use of Conjoint Analysis in Health Outcomes Research: An Examination of the Literature.” The International Society for Pharmacoeconomics and Outcomes Research, Orlando, Florida, May 2009. (Poster Presentation)

40. Qureshi Z.P., Szeinbach S.L., Seoane-Vazquez E. “Market Discontinuation of Pharmaceuticals in the United States: Analysis of New drugs Approved from 1980 to 2007.” The International Society for Pharmacoeconomics and Outcomes Research, Toronto, Canada, May 2008. (Oral Presentation)

41. Muzumdar J., Chung Y., Qureshi Z.P., Siganga W. “Pharmacy Students Perceptions on the Use of Coping Mechanisms to Overcome Depression.” Ohio Pharmacists Association Annual Meeting, Columbus, OH, April 2005. (Oral Presentation)

42. Muzumdar J., Chung Y., Qureshi Z.P., Siganga W. “Pharmacy Students Perceptions on the Use of Coping Mechanisms to Overcome Depression.” American Pharmacists Association Annual Convention, Orlando, FL, April 2005. (Poster Presentation)

43. Qureshi Z.P., Muzumdar J., Chung Y., Siganga W. “Pharmacy Students’ Knowledge and Attitude toward Emergency Contraception.” Ohio Pharmacists Association Annual Meeting, Columbus, OH, April 2005. (Poster Presentation)

44. Qureshi Z.P., Poddar S. “Banned Drugs: Current National Status.” 55th Indian Pharmaceutical Congress, Chennai, India, December 2003. (Oral Presentation)

45. Qureshi Z.P., Wadhwani K, Poddar S. “Total Quality Management: Ground Level Facts.” 55th Indian Pharmaceutical Congress, Chennai, India, December 2003. (Poster Presentation)

46. Qureshi Z.P., Poddar S. “Evaluation of Pharmacy Exam Pattern at Undergraduate level.” 54th Indian Pharmaceutical Congress, Pune, India, December 2002. (Poster Presentation)

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

G R A N T S

1. Title: Who’s Watching MedWatch: An assessment of hematology-oncology drugs and VTE reporting Funding agency: Doris Levkoff Meddin Medication Safety Education Program Amount: $12,944, 2012-2013 PI: Whitney Maxwell; Role: Co-Investigator This project aims to propose strategies for standardization of FDA MedWatch ADR reporting forms for common ADRs like VTE, and determine if submission of incomplete clinical data reduces the quality of MedWatch reporting forms. 2. Title: National Changes in Erythropoiesis Stimulating Agents (ESAs) Before and After Dissemination of Black Box Warnings and Implementation of National Coverage Decisions and Risk Evaluation and Mitigation Strategies (REMS) in the cancer settings Funding agency: Doris Levkoff Meddin Medication Safety Education Program Amount: $15,000, 2012-2013 PI: Jun Wu; Role: Co-Investigator This study involves a secondary database analysis that evaluates patterns of care for ESAs, an important drug that is used extensively in oncology and the chronic kidney disease settings. 3. Title: South Carolina Opioid Safety Initiative (SCOSI) Funding Agency: The US Food and Drug Administration Amount: $49,684; Jan 2012 – Dec 2012 – extension to Dec 2013 PI: Charles Bennett; Role: Post-Doctoral Associate SCOSI is a novel grant that seeks to lay the foundation for training health care professionals in the use of Prescription Monitoring Program of South Carolina and also in evidence based approaches to opioid prescribing. In the short term, it will develop a statewide collaboration that will propose a Blueprint for a long-lasting initiative to decrease rates of misuse, overuse, and under abuse of opioid narcotics to cancer patients and will evaluate a statewide database to identify individual physicians who are high prescribers of opioids to cancer patients. 4. Title: Long-term adherence to hormone therapy and associated outcomes in women with primary breast cancer Funding agency: ASPIRE I - University of South Carolina Amount: $ 14,046, May 2011 – April 2013 PI: Jun Wu; Role: Research Associate The objective of this project is to assess the adherence to adjuvant hormone therapy and associated outcomes including healthcare utilization and costs in patients with primary breast cancer using South Carolina Medicaid data linked to South Carolina Central Cancer Registry (SCCCR). 5. Title: Determining Patterns of Opioid Misuse and Misprescribing in South Carolina Funding agency: ASPIRE I - University of South Carolina Amount: $ 11,687, 2014 – 2015 PI: Zaina Qureshi The objective of this project is to conduct an epidemiologic analysis of South Carolina prescription data to determine patterns of opioid prescribing, and to use geo-spatial mapping to identify geographical locations with the highest rates of opioid misuse for targeted interventions within the state.

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

G R A N T S c o n t i n u e d

6. Title: Improving Colorectal Cancer Screening Adherence through Adaptive Choice Funding agency: Institute for the Advancement of Healthcare at USC Amount: $ 30,000, 2014 – 2015 PI: Zaina Qureshi The objective of this project is to determine the perception and understanding of patients below the age 50 regarding Colorectal Cancer screening methods. 7. Title: Understanding the Impact of Prostate Cancer Screening among US Veterans Funding agency: Institute for the Advancement of Healthcare at USC Amount: $ 6,000, 2014 – 2015 PI: Zaina Qureshi The objective of this project is to understand patient knowledge regarding prostate cancer screening and to evaluate the impact of PSA screening on mental health outcomes. 8. Title: Economic impact of Tuberculosis among Bangladeshi population and Economic Evaluation of the Current Approaches of Tuberculosis Control in Bangladesh Funding agency: WHO TDR Amount: $ 50,000, 2014 – 2018 PI: Rifat Haider; Role: Mentor The objective of this project is to assess economic impact of drug sensitive and drug resistant tuberculosis on the afflicted population of Bangladesh. 9. Title: Saudi Arabia Research and Training Program Funding agency: King Saud Bin Abdulaziz University for Health Sciences Amount: $ 475,428, 2014 – 2016 PI: Mahmud Khan; Role: Research and Training Coordinator The objective of this project is to encourage collaboration between the Arnold School of Public Health and King Saud Bin Abdulaziz University for Health Sciences. 10. Title: Establishing Screening Strategies for Prostate Cancer Patients Funding agency: ASPIRE II - University of South Carolina Amount: $ 99,786, 2015 – 2016 PI: Zaina Qureshi The objective of this proposal is to use retrospective data to develop scientifically sound PSA screening strategy for early detection of prostate cancer. 11. Title: Identifying genomic risk factors for long-term disability among persons who receive one or two doses of ciprofloxacin Funding agency: ACS SOAR Amount: $ 30,000, 2016 – 2017 PI: Zaina Qureshi This study aims to evaluate DNA for pharmacogenomics predictors of Fluoroquinolone Associated Disability (FQAD) associated with ciprofloxacin administration using whole exome sequencing.

12. Title: Genomic markers for fluoroquinolone associated disability Funding agency: Dorn Research Institute Seed Grant Amount: $ 5,500, 2017 – 2018 PI: Zaina Qureshi This study aims to use polymerase chain reaction (PCR) analysis to identify specific predictors of Fluoroquinolone Associated Disability (FQAD) associated with ciprofloxacin administration. 13. Title: Opportunistic Infections in Chronic Lymphoid leukemia (CLL) Patient Population Funding agency: Pharmacyclics, LLC an Abbvie company Amount: $ 97,786, 2017 – 2018 Co-PI: Zaina Qureshi This study aims to conduct a study using existing Veterans Affairs (VA) data to (1) characterize the risk for opportunistic infections in chronic lymphoid leukemia patients that receive treatment for chronic lymphoid leukemia, mantle cell lymphoma, Waldenstrom’s macroglobulinemia, marginal zone lymphoma, multiple myeloma, and primary central nervous system lymphoma. 14. Title: Decision Aid Implementation for Colorectal Cancer Screening in Primary Settings Funding agency: American Cancer Society, Colorectal Cancer Partnership Award Amount: $ 5,000, 2017 – 2018 PI: Meenu Jindal, Role: Consultant This study aims to use decision aids to help initiate discussion regarding colorectal cancer screening (CRCS) to increase the opportunity for discussions between primary care physicians and patients regarding CRCS.

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

G R A N T S c o n t i n u e d

HSPM 500 - Introduction to Healthcare Management and Organization HSPM 700 - Approaches and Concepts for Health Administration HSPM 775 - Managerial Epidemiology and Statistics in Healthcare HSPM 719 - Health Services Research Methods II HSPM 800 - Doctoral Seminar in Health Services Policy and Management HSPM 797 - Management Residency HSPM 890 - Independent Study – Applications of Research Methods including Methodologies assessing Patient Preferences, Cancer Pharmacoepidemiology and Economic Evaluation in Cancer Research

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

C O U R S E S O F F E R E D

Doctoral Students

Jeremy Faulkenburg Association of provider communication and inpatient hospital readmissions Hamad Alzamanan Are post-acute care, hospital characteristics and payer type associated with 30-

day readmission rate for Total Joint Arthroplasty George Newby Practice Considerations Associated with the Provision of Health Education

Services to Patients by Primary Care Providers Sean Wu Antihyperglycemic Adherence and Risk of Stroke among Type II diabetes

mellitus: A Population-based Retrospective Cohort Study Wendy Li Assessment of an innovative screening colonoscopy protocol using a 2-person

technique and propofol sedation relative to the performance quality of primary care physicians and specialists

Grishma Patel Association between electronic prescribing and adverse drug event hospitalization rates for older adults: an ecological and discharge-level analysis

Ashley Barnes Relationship between Job Satisfaction among Frontline Staff and Patient Satisfaction: Evidence from Community Health Centers in South Carolina

Yu-Hsiu Lin Community-Level Factors Associated with Health-Related Quality of Life among Older Adults

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

S T U D E N T A D V I S E M E N T

MHA Students

Steven Tyler Miles

WJB Dorn VA Medical Center: Emergency Department Systems Redesign

Punam Patel The Impact of Leadership Engagement on Operational Performance Sara Montgomery Three Year Marketing Plan for Palmetto Health Senior Consulting Andrew Myers

Capturing Workforce Productivity in Rehabilitation Services at Palmetto Health: An Analysis of Methodologies, Development of a Mechanism, and Recommendations for Improvement

Bryan Jenkins Evaluating the Effectiveness of MDInsight: Improving the Delivery of Care under the PCMH Model at Palmetto Health

Amanda Kitchings Population Health at Providence Hospitals Stephen White Nurse Practitioner Models and Scope of Practice at ColoRectal Associates

Brennan Bogner Exploring Oncology Medical Homes in SC Medicaid Katherine Carter Development of a Change Management Toolkit for Use throughout Accountable

Care Unit (ACU) Implementation Colin Beilman Customer Contact Center Process Improvement Initiative and FTE Analysis Brian Beverly PCMH Transition Toolkit Frederick Dymock Evaluation, Analysis, and Business Plan for the Palmetto Health D.W. Reynolds

Grant Jeffery Homad System Integration to Optimize Clinical Units at Palmetto Health Richland Eric Moss Transitioning to a Population Health-Based Care Delivery Model for Sickle Cell

Patients Leila Sadegh HPV vaccine is cancer prevention Hannah Sheely Selection, Implementation, and Evaluation of a Patient Relationship Management

System

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

S T U D E N T A D V I S E M E N T c o n t i n u e d

MPH Students

Cameron Edmonds The Best Chance Network - Provider Survey Ana Isabel Gallego Londono

Achieving the Triple Aim in South Carolina: Structure and Goals

Dallas Gordon Action Plan for Employee Engagement in the Midlands Alison Grossman The Development of the National Ability Center East Coast Campus

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

S T U D E N T A D V I S E M E N T c o n t i n u e d

Served as a reviewer for the following publications: 1. BioMed Central Health Services Research 2. Cancer 3. Urology 4. Journal of Evaluation in Clinical Practice 5. Medical Care 6. Clinical Genitourinary Cancer 7. Journal of Cancer Education 8. American Journal of Mens Health 9. Substance Abuse

International Society for Pharmacoeconomics and Outcomes Research

Reviewer for Presentations – Oral and Poster

International Society for Pharmacoeconomics and Outcomes Research Reviewer for Abstracts

ZAINA QURESHI A S S I S T A N T P R O F E S S O R

I N V I T E D R E V I E W E R